Patents by Inventor Shawn Rose

Shawn Rose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for increasing mannose content of recombinant proteins
    Patent number: 11952605
    Abstract: The present invention relates to methods of modulating the mannose content of recombinant proteins.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: April 9, 2024
    Assignee: Amgen Inc.
    Inventors: Jian Wu, Sean Davern, Simina Crina Petrovan, Michael Charles Brandenstein, Katherine Rose Lindahl, Shawn Erik Lillie
  • Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
    Publication number: 20230277665
    Abstract: A method of treating active Systemic Lupus Erythematosus (SLE) in a patient by administering a clinically proven safe and clinically proven effective amount of an anti-IL-12/IL-23p40 antibody or an anti-IL-23 antibody, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, wherein the patient achieves a significant improvement in disease activity.
    Type: Application
    Filed: December 13, 2022
    Publication date: September 7, 2023
    Inventors: Shawn Rose, Carrie Wagner
  • IL-23 Specific Antibodies for the Treatment of Systemic Sclerosis
    Publication number: 20230212280
    Abstract: A method of treating systemic sclerosis in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial dose and subsequent doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
    Type: Application
    Filed: December 16, 2022
    Publication date: July 6, 2023
    Inventors: Takemichi Fukasawa, Sheng Gao, Nobukazu Kakui, Naoko Kawashima, Takayuki Kimura, Hitomi Morishima, Ernesto Munoz, Shawn Rose, Takehiko Sakamoto, Shinichi Sato, John Toso, Yoshifumi Ukyo, Ayumi Yoshizaki, Richuan Zheng
  • Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
    Publication number: 20200197517
    Abstract: A method of treating active Systemic Lupus Erythematosus (SLE) in a patient by administering a clinically proven safe and clinically proven effective amount of an anti-IL-12/IL-23p40 antibody or an anti-IL-23 antibody, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, wherein the patient achieves a significant improvement in disease activity.
    Type: Application
    Filed: December 17, 2019
    Publication date: June 25, 2020
    Inventors: Shawn Rose, Carrie Wagner
  • Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
    Publication number: 20190092853
    Abstract: A method of treating active Systemic Lupus Erythematosus (SLE) in a patient by administering a clinically proven safe and clinically proven effective amount of an anti-IL-12/IL-23p40 antibody or an anti-IL-23 antibody, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, wherein the patient achieves a significant improvement in disease activity.
    Type: Application
    Filed: September 24, 2018
    Publication date: March 28, 2019
    Inventors: Shawn Rose, Carrie Wagner
  • Dual Mode Jack Foot
    Publication number: 20090236577
    Abstract: The dual mode jack foot of the present invention is designed for attachment to the base of most commercially available trailer jacks. The inventive jack foot includes a housing pivotally attached to an end of a trailer jack, and first and second types of trailer support mechanisms attached to the housing approximately 90-degrees apart. The housing is pivotable between a first position wherein the first type of trailer support mechanism is deployed for use, and a second position wherein the second type of trailer support mechanism is deployed for use.
    Type: Application
    Filed: March 20, 2009
    Publication date: September 24, 2009
    Applicant: Concurrent Technologies Corporation
    Inventors: Michael John Pollock, Vaughan Gordon Stevenson, John Ellsworth Gover, JR., David Shawn Rose